Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities
Clinical trial NCT01401452 · COMPLETED
Trial details
- NCT number
- NCT01401452
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-08-01
- Primary completion
- 2016-05-01
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.